ProCE Banner Activity

Importance of Early Recognition and Management of Immune-Related Adverse Events to Optimize Outcomes With Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer and Other Malignancies

Clinical Thought

Commentary by an NP with extensive experience treating patients with immune checkpoint inhibitors (ICIs) about providing education for patients, caregivers, and the healthcare team to prevent, anticipiate, detect, and treat immune-related adverse events to maximize outcomes with ICIs. 

Released: November 29, 2022

Expiration: November 28, 2023

No longer available for credit.
Begin Activity



Marianne Davies

Marianne Davies, DNP, ACNP, FAAN

Associate Professor
Yale School of Nursing
Senior Advanced Practice Nurse
Smilow Cancer Hospital at
Yale New Haven
Yale Comprehensive Cancer Center
New Haven, Connecticut

Provided by

ProCE Banner


This activity is supported by

Regeneron Pharmaceuticals, Inc

Faculty Disclosure

Marianne Davies,DNP, ACNP, FAAN, has no relevant financial relationships to disclose.

Additional Information

Program Medium

This program has been made available online.